Neurogene Inc.
NGNE | NASDAQ
$32.57
+$0.48 (+1.50%)
At close: Sep 21, 2026, 4:00 PM ET
$32.57
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -4.86 | -5.34 | -6.85 | -2.37 | -104.78 | -440.63 |
PEG Ratio | 5.20 | -0.10 | 0.20 | -0.01 | -2.40 | 5.87 |
PS Ratio | n/a | 434.14 | n/a | n/a | n/a | n/a |
PB Ratio | 1.65 | 1.29 | 1.34 | 1.32 | -57.75 | 76.43 |
P/FCF Ratio | -5.57 | -5.62 | -4.80 | -2.37 | -81.92 | -545.45 |
P/OCF Ratio | -5.65 | -5.69 | -4.83 | -2.47 | -114.35 | -594.70 |
OCF/S Ratio | n/a | -7.63K | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.04 | 0.04 | 0.09 | 0.05 | -0.07 | 0.06 |
Quick Ratio | 16.56 | 20.84 | 8.72 | 12.74 | 6.64 | 24.66 |
Current Ratio | 16.56 | 20.84 | 8.72 | 12.74 | 6.81 | 24.66 |
Asset Turnover | n/a | 0 | n/a | n/a | n/a | n/a |
Interest Coverage | -20.64K | -6.88K | -4.63K | -28.26K | n/a | n/a |
Return on Equity | -34.11% | -24.21% | -19.52% | -55.96% | 54.98% | -17.40% |
Return on Assets | -31.31% | -22.38% | -16.32% | -50.51% | -49.78% | -15.81% |
Return on Invested Capital | -37.50% | -25.53% | -27.45% | -54.70% | -54.65% | -20.44% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -251.03% | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | -8.12K% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -8.12K% | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | -8.93K% | n/a | n/a | n/a | n/a |
FCF Margin | n/a | -7.72K% | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -7.77K% | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NGNE